Cadila Healthcare Limited

Rediff.com » News » Cadila Healthcare Limited

News for Cadila Healthcare Limited

News
Business

Zydus' Virafin gets emergency use approval for treating moderate COVID-19 cases

The Drugs Controller General of India has approved emergency use for Zydus Cadila's Pegylated Interferon alpha-2b, 'Virafin' for treating moderate COVID-19 infection in adults. A release by Cadila......

Shots of Covid vaccine to be taken 28 days apart: AIIMS chief

As India gears up for the world's largest vaccination programme, the ministry of health and family welfare addressed apprehensions expressed by the public regarding the COVID-19 vaccine's......

Vaccination for COVID-19 will be voluntary: Govt

Getting vaccinated for COVID-19 will be voluntary, the Union health ministry has said while underlining that the vaccine introduced in India will be as effective as any vaccine developed by other......

India biggest buyer of Covid vaccine with 1.6 bn doses

India is the largest buyer of COVID-19 vaccines in the world with 1.6 billion doses, according to a global analysis, a number some scientists say could cover 800 million people, or 60 per cent of......

COVID vaccine likely to be available by first of 2021: Choubey

If the advanced clinical trials of COVID-19 vaccine succeed, then an effective vaccination is likely to be available by the end of first quarter of 2021, Minister of State for Health Ashwini......

4 Indian drug firms recall products in US market

Indian drug firms like Marksans Pharma, Aurobindo Pharma, Zydus and Jubilant are recalling products in the US market, as per the latest enforcement report by the US Food and Drug......

2018: Year of reckoning for India Inc

A glance back at some important ups and down India Inc faced in 2018. Year End Specials Kindly click on the image below to view the relevant story. #1 How PNB scam effected consumer......

Can these stocks shine amid market gloom?

Investors turn their attention to export-driven sectors, experts tell Krishna Kant. Illustration: Uttam Ghosh After betting on the domestic consumption story for over three years, equity investors......

Markets end first trading session of 2016 on a tepid note

The S&P BSE Sensex closed at 26,190, up by 43 points and Nifty50 settled above 7,950 to end at 7,963, up by 17 points Markets ended the first day of the New Year on a tentative note as selling......

Markets make handsome gains on December F&O expiry

Markets scaled higher on the last day of December derivatives series due to strength in energy and index heavyweight shares such as HDFC and Infosys. The S&P BSE Sensex ended higher 158 points at......

Rediff News

Cadila Healthcare Limited

News for Cadila Healthcare Limited

Zydus' Virafin gets emergency use approval for treating moderate COVID-19 cases

Shots of Covid vaccine to be taken 28 days apart: AIIMS chief

Vaccination for COVID-19 will be voluntary: Govt

India biggest buyer of Covid vaccine with 1.6 bn doses

COVID vaccine likely to be available by first of 2021: Choubey

4 Indian drug firms recall products in US market

2018: Year of reckoning for India Inc

Can these stocks shine amid market gloom?

Markets end first trading session of 2016 on a tepid note

Markets make handsome gains on December F&O expiry

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS